Avicanna Inc. (AVCNF)
OTCMKTS · Delayed Price · Currency is USD
0.1650
-0.0020 (-1.20%)
Dec 24, 2025, 4:00 PM EST
Avicanna Revenue
Avicanna had revenue of 6.40M CAD in the quarter ending September 30, 2025, with 1.96% growth. This brings the company's revenue in the last twelve months to 25.50M, up 2.41% year-over-year. In the year 2024, Avicanna had annual revenue of 25.46M with 51.62% growth.
Revenue (ttm)
25.50M CAD
Revenue Growth
+2.41%
P/S Ratio
1.08
Revenue / Employee
293.05K CAD
Employees
87
Market Cap
19.85M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 25.46M | 8.67M | 51.62% |
| Dec 31, 2023 | 16.79M | 12.74M | 314.82% |
| Dec 31, 2022 | 4.05M | 778.98K | 23.83% |
| Dec 31, 2021 | 3.27M | 1.70M | 108.20% |
| Dec 31, 2020 | 1.57M | 1.40M | 833.16% |
| Dec 31, 2019 | 168.25K | 50.28K | 42.62% |
| Dec 31, 2018 | 117.97K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 196.17M |
| Global Cord Blood | 196.10M |
| Elite Pharmaceuticals | 122.89M |
| Silence Therapeutics | 25.83M |
| OpGen | 9.00M |
| Northwest Biotherapeutics | 937.00K |
Avicanna News
- 1 day ago - Avicanna Announces Changes to its Board of Directors - GlobeNewsWire
- 5 days ago - Avicanna Applauds President Trump's Executive Order to Reclassify Cannabis & Provides Scientific Update - GlobeNewsWire
- 7 days ago - Avicanna Inc. (AVCN:CA) Discusses Strategic Pivot, Business Pillars, and Pharmaceutical Pipeline Progress Transcript - Seeking Alpha
- 5 weeks ago - Avicanna Announces Pre-Clinical Data Supporting Enhanced Absorption and Patent Filing for Novel Oral Delivery Platform - GlobeNewsWire
- 5 weeks ago - Avicanna Reports Q3 2025 - GlobeNewsWire
- 3 months ago - Avicanna Announces Change in CFO - GlobeNewsWire
- 4 months ago - Avicanna Subsidiary Completes Export of CBD Dominant Cannabis Flower into Switzerland - GlobeNewsWire
- 4 months ago - Avicanna LATAM SAS Teams Up With Harrington Wellness to Launch re+PLAY CBD Wellness Brand Topicals in the United States - GlobeNewsWire